Dr. OZGE GUMUSAY
Snapshot Highlights
- Professor at Acıbadem University Faculty of Medicine
- Associate Professor designation at two prestigious institutions
- Extensive experience in Medical Oncology, including advanced research at UCSF and Stanford
- Published author with significant contributions to breast cancer research and immunotherapy
- Member of leading international oncology societies including ASCO and ESMO
Professional Experience
Dr. Ozge Gumusay brings over two decades of dedicated experience in internal medicine and medical oncology, establishing a robust clinical and academic career. Her journey in oncology includes significant roles at Acıbadem Health Group, where she holds a professorship. Prior to this, Dr. Gumusay enriched her expertise through impactful visiting observer roles at the Stanford University Comprehensive Cancer Center and extensive work at the UCSF Helen Diller Family Comprehensive Cancer Center, focusing on breast cancer oncology. Her academic progression is marked by her tenure as an Associate Professor at Gaziosmanpaşa University Faculty of Medicine, where she also served as a Medical Oncology Specialist. Earlier in her career, she contributed as an Assistant Professor and research assistant in medical oncology at Gaziosmanpaşa University and Gazi University, respectively, gaining foundational experience in internal medicine at Gazi University.
Education
Dr. Gumusay’s educational foundation is distinguished by her academic appointments at Acıbadem University Faculty of Medicine, culminating in a Professor position in 2023 and Associate Professor in 2022. She also achieved Associate Professor status at Gaziosmanpaşa University Faculty of Medicine in 2017. Her specialization in Medical Oncology was achieved through rigorous training at Gazi University Faculty of Medicine in 2014, following her completion of Internal Medicine residency at the same esteemed institution in 2010. Her medical degree was earned from Hacettepe University Faculty of Medicine in 2005, laying the groundwork for her impactful career in cancer care and research.
Memberships
Dr. Gumusay is an active and respected member of several leading professional organizations in the field of oncology. These include the American Society of Clinical Oncology (ASCO), The European Society of Medical Oncology (ESMO), and the Turkish Medical Oncology Association (TTOD). Her participation in these societies underscores her commitment to staying at the forefront of oncological advancements and collaborative research.
Publications
Dr. Ozge Gumusay is a prolific researcher with numerous publications focusing on critical areas within medical oncology, particularly breast cancer and immunotherapy. Her research explores mechanisms of resistance to CDK4/6 inhibitors and identifies potential biomarkers for treatment responsiveness in breast cancer, as published in Future Oncology. She has made significant contributions to understanding and managing immunotherapy toxicity, with a notable publication in Breast Cancer Research and Treatment. Dr. Gumusay also holds shared first authorship on a publication in Frontiers in Oncology regarding immunotherapy in breast cancer and the potential role of liquid biopsy. Her work extends to emerging treatment strategies for metastatic triple-negative breast cancer, as featured in Therapeutic Advances in Medical Oncology, and she has been involved in trials of immunotherapy for triple-negative breast cancer, published in Current Breast Cancer Reports. Other notable contributions include research on Pembrolizumab for early triple-negative breast cancer in The New England Journal of Medicine, and strategic combinations to overcome targeted therapy resistance in oncology. Her earlier research addressed factors influencing chemotherapy goal perception in cancer patients and discordances in HER2 status in gastric cancer.